Cargando…
Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks
ADAM10 is a metalloproteinase acting on the amyloid precursor protein (APP) as an alpha-secretase in neurons. Its enzymatic activity results in secretion of a neuroprotective APP cleavage product (sAPP-alpha) and prevents formation of the amyloidogenic A-beta peptides, major hallmarks of Alzheimer’s...
Autores principales: | Reinhardt, Sven, Stoye, Nicolai, Luderer, Mathias, Kiefer, Falk, Schmitt, Ulrich, Lieb, Klaus, Endres, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778060/ https://www.ncbi.nlm.nih.gov/pubmed/29358714 http://dx.doi.org/10.1038/s41598-018-19577-7 |
Ejemplares similares
-
Repression of Alzheimer's beta-Secretase
por: Liao, Francesca-Fang, et al.
Publicado: (2013) -
γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022) -
Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay
por: Schulze, Sarina, et al.
Publicado: (2015) -
Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms
por: Endres, Kristina, et al.
Publicado: (2017) -
Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2012)